{{Rsnum
|rsid=10919035
|Gene=NOS1AP
|Chromosome=1
|position=162274222
|Orientation=plus
|GMAF=0.2603
|Gene_s=NOS1AP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 76.9 | 23.1 | 0.0
| HCB | 44.4 | 42.2 | 13.3
| JPT | 37.8 | 48.9 | 13.3
| YRI | 63.5 | 34.9 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 44.4 | 42.2 | 13.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22682551
|Title=Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT Prolongation and Ventricular Arrhythmia
|OA=1
}}
{{PMID Auto
|PMID=24922963
|Title=163 Genetic Modifiers in Carriers of the SCN5A E1784K Mutation with Variable Phenotypic Expression - Long QT3 / Brugada Syndrome Overlap Disease
}}